Enterprise Value
-6.887M
Cash
33.98M
Avg Qtr Burn
-5.159M
Short % of Float
0.44%
Insider Ownership
25.05%
Institutional Own.
13.09%
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
CC-31244 (Pan-genotypic NS5B NNI) Details Hepatitis C | Phase 2a Update | |
CC-42344 Details Influenza | Phase 2a Initiation | |
CDI-988 Details COVID-19 | Phase 1 Initiation | |
CDI-45205 Details COVID-19 | IND Submission |